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179* Analysis of local ﬂow and resistance in the lower airways in ﬁve
children suffering from cystic ﬁbrosis using computational ﬂuid
dynamics
W. Vos1, J. De Backer1, S. Verhulst3, K. Desager2, W. De Backer1. 1Pulmonology,
University Hospital Antwerp, Antwerp, Belgium; 2CF clinic, Pediatrics, University
Hospital Antwerp, Antwerp, Belgium; 3Pediatrics, University Hospital Antwerp,
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Five children (13±3.6 y) suffering from CF are being studied using a novel functional
imaging method. The aim is to understand the consequences of bronchiectasies on the
airﬂow mechanics in the lower airways.
High resolution low radiation dose CT scans of all 5 patients at total lung capacity have
been taken to visualize the amount of airway deformation. Through 3D reconstruction,
a better idea of the actual extent, impact and location of these deformations could be
obtained.
The 3D models could be made functional by means of computational ﬂuid dynamics
(CFD) techniques. CFD simulates ﬂow behavior throughout the airways based on the
Navier-Stokes equations. Very local ﬂow characteristics such as intraluminal pressure
and velocities could be obtained. From these it is possible to calculate airway resistance
(RAW). RAW provides an indication of the dynamic capabilities of the respiratory
system. First analyses showed that bronchiectasies increase RAW, thereby affecting the
lung function. Regions with high RAW in the table correspond with inﬂamated regions
in the 3D model.
The technique is believed to provide a deeper insight in the CF problematic towards




Upper Lobe Right 23.2
Middle Lobe Right 30.3
Lower Lobe Right 11.0
Upper Lobe Left 26.3
Lower Lobe Left 9.2
180 Assessment of the impact of a dedicated multi disciplinary
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Aim: To assess the beneﬁt to patient care of a dedicated CF consultant and
multidisciplinary team by assessing:
a. CF patient weight and height centiles, body mass index (BMI), lung function,
patient microbiology, prevalent, CF related diabetes (CFRD) and liver disease
(CFLD) and comparing to data from international tertiary CF centres.
b. If UK CF Trust and Cystic Fibrosis Foundation Guidelines are adhered to
regarding regularity of CF clinics, and annual investigations.
c. CF services development.
Method: Data was collected prospectively from annual assessments, CF clinics,
inpatient stays and “daily walk in clinics.
Results:
1. CF lung function, BMI for weight, height, microbiology and incidence of CFRD
compared favourably to international CF tertiary CF centres. CFLD is more
prevalent in Ireland.
2. International guidelines are adhered to regarding 3 monthly clinics, annual
assessment and annual investigations.
3. New CF services include: Daily “walk in” CF clinic, 6 week parents’ educational
evening courses, joint CF dietician and CF psychologist sessions for feeding
problems, joint CF nurse specialist and CF psychologist for intravenous access
problems.
All parents were educated in administering intravenous home antibiotics except
where social circumstances prevented.
Conclusion: This work conﬁrms previous studies that patients attending a CF centre
with a multidisciplinary CF team beneﬁt regarding CF care and services. Because
many children are still too young to perform PFT’s, the beneﬁts to lung function
remains to be proven.
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Individualized Cystic Fibrosis Clinic began in 1989 in the Paediatrics Department
of our hospital. The expanding life expectancy of these patients has lead us to
implement a transition program from the Paediatrics to the Respiratory Medicine
Department, which began in 2000.
The aim of this study is to evaluate two of the transition deﬁned criteria: age above
18 years old and clinical stability. From 106 patients followed, 31 were included
under the deﬁned criteria, one female adolescent was included because of her two
CF adult siblings (group A: n = 32). Seven patients were not included due to clinical
instability (group B: n = 7).
The mean age was 25 (13−41) years in the group A and 22 (19−26) years in the
group B. The mean FEV1 (% predicted) was 54.5 (15–108) for group A and 29
(20−43) for group B.
After ﬁve years of follow-up, the mean FEV1 (% predicted) for the group A
survivors (n = 27) was 55 (15–108). The mortality rate was 16% in group A and 86%
in group B. Among the patients that died the median survival time was 39 months in
group A and 6.5 months in group B. The only survivor from group B was submitted
to bilateral lung transplant.
Our conclusion is that clinical stability must be considered as a transition criteria.
Patients with advanced disease must be spared the stress that is part of the transition
process.
